Clinical Trial Update: Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating neoadjuvant EGFR-targeted therapy in patients with resectable EGFR-mutated lung squamous cell carcinoma, currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Investigational EGFR-targeted therapy

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Lung Cancer, Carcinoma, Squamous Cell | Phase 2 | Status: RECRUITING